Article
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Journal of the National Cancer Institute - 15 Jan 1997
Lerman C, Biesecker B, Benkendorf J L, Kerner J, Gomez-Caminero A, Hughes C, Reed M M
Abstract excerpt
BACKGROUND: In response to the isolation of the BRCA1 gene, a breast-ovarian cancer-susceptibility gene, biotechnology companies are already marketing genetic tests to health care providers and to the public. Initial studies indicate interest in BRCA1 testing in the general public and in populations at high risk. However, the optimal strategies for educating and counseling individuals have yet to be determined....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
